×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

South Korea Pharmacy Market

ID: MRFR/MED/50762-HCR
200 Pages
Garvit Vyas
October 2025

South Korea Pharmacy Market Research Report By Product Type (Prescription Drugs, Over-The-Counter Drugs, Vaccines, Homeopathic Medicine), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy, Specialty Pharmacy), By Therapeutic Area (Cardiovascular, Oncology, Diabetes, Neurology, Infectious Diseases) and By Formulation (Tablets, Injectables, Topicals, Liquids)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

South Korea Pharmacy Market Infographic
Purchase Options

South Korea Pharmacy Market Summary

As per MRFR analysis, the South Korea pharmacy market Size was estimated at 22.5 USD Billion in 2024. The South Korea pharmacy market is projected to grow from 23.42 USD Billion in 2025 to 35.0 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 4.1% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The South Korea pharmacy market is experiencing a transformative shift driven by digital innovation and a focus on preventive healthcare.

  • Digital transformation is reshaping the pharmacy landscape, enhancing service delivery and customer engagement.
  • The preventive healthcare focus is gaining traction, encouraging consumers to prioritize health management and wellness.
  • Regulatory support for innovation is fostering a conducive environment for new pharmacy solutions and services.
  • The aging population and rising health awareness are major drivers propelling market growth in South Korea.

Market Size & Forecast

2024 Market Size 22.5 (USD Billion)
2035 Market Size 35.0 (USD Billion)
CAGR (2025 - 2035) 4.1%

Major Players

CVS Health (US), Walgreens Boots Alliance (US), Roche (CH), McKesson (US), Cigna (US), Cardinal Health (US), AstraZeneca (GB), Sanofi (FR), GSK (GB), Novartis (CH)

South Korea Pharmacy Market Trends

The pharmacy market in South Korea is currently experiencing a dynamic transformation, driven by various factors including technological advancements and changing consumer behaviors. The integration of digital health solutions is becoming increasingly prevalent, as pharmacies adopt e-commerce platforms and telepharmacy services to enhance accessibility and convenience for patients. This shift not only improves the customer experience but also allows pharmacies to expand their reach beyond traditional brick-and-mortar locations. Furthermore, the growing emphasis on preventive healthcare is influencing the types of products and services offered, with pharmacies increasingly providing health screenings and wellness consultations. In addition to technological integration, regulatory changes are shaping the landscape of the pharmacy market. The South Korean government is actively promoting policies that encourage innovation and competition within the sector. This includes initiatives aimed at improving the supply chain and ensuring the availability of essential medications. As a result, pharmacies are likely to adapt their business models to align with these regulations, potentially leading to enhanced service offerings and improved patient outcomes. Overall, the pharmacy market in South Korea appears poised for continued growth, driven by a combination of technological advancements and supportive government policies.

Digital Transformation

The pharmacy market is witnessing a significant shift towards digital solutions. Pharmacies are increasingly adopting e-commerce platforms and telehealth services, allowing for greater accessibility and convenience for consumers. This trend is likely to enhance customer engagement and expand market reach.

Preventive Healthcare Focus

There is a growing emphasis on preventive healthcare within the pharmacy market. Pharmacies are expanding their services to include health screenings and wellness consultations, reflecting a shift in consumer preferences towards proactive health management.

Regulatory Support for Innovation

The South Korean government is implementing policies that foster innovation in the pharmacy market. These regulatory changes aim to improve supply chain efficiency and ensure the availability of essential medications, encouraging pharmacies to adapt and enhance their service offerings.

South Korea Pharmacy Market Drivers

Aging Population Impact

The aging population in South Korea is a crucial driver for the pharmacy market. As the demographic shifts towards an older age group, the demand for pharmaceuticals and healthcare services is expected to rise significantly. By 2025, it is projected that over 20% of the population will be aged 65 and above, leading to increased prevalence of chronic diseases. This demographic trend necessitates a robust pharmacy market to cater to the growing needs for medications, consultations, and health management services. Furthermore, the pharmacy market is likely to see a surge in demand for specialized medications tailored for geriatric patients, thereby influencing market dynamics and growth strategies for pharmacy operators.

Rising Health Awareness

Rising health awareness among the South Korean population is significantly influencing the pharmacy market. With an increasing focus on preventive healthcare and wellness, consumers are more inclined to seek out pharmacies for health consultations and over-the-counter products. Surveys indicate that nearly 70% of South Koreans are actively seeking information about health and wellness, which is driving demand for health-related products and services. This trend is likely to propel the pharmacy market towards offering a wider range of health supplements, preventive medications, and wellness programs. Consequently, pharmacies are adapting their business models to include health education and preventive care services, thereby enhancing their role in the healthcare ecosystem.

E-commerce Growth in Pharmacy

The growth of e-commerce is emerging as a significant driver for the pharmacy market in South Korea. With the increasing penetration of the internet and mobile devices, consumers are increasingly turning to online platforms for purchasing medications and health products. As of 2025, it is estimated that online sales in the pharmacy market could account for over 25% of total sales, reflecting a shift in consumer behavior. This trend is prompting traditional pharmacies to enhance their online presence and develop e-commerce strategies to remain competitive. Furthermore, the convenience of home delivery services and online consultations is likely to attract a broader customer base, thereby transforming the landscape of the pharmacy market.

Government Initiatives and Policies

Government initiatives and policies play a pivotal role in shaping the pharmacy market in South Korea. The government has been actively promoting policies aimed at improving access to medications and enhancing the quality of healthcare services. Recent reforms have focused on reducing drug prices and increasing the availability of essential medicines, which is expected to stimulate growth in the pharmacy market. Additionally, the government is investing in healthcare infrastructure, which includes expanding pharmacy services in rural areas. These initiatives are likely to create a more favorable environment for pharmacy operations, encouraging innovation and competition within the market.

Technological Advancements in Pharmacy

Technological advancements are reshaping the pharmacy market in South Korea. Innovations such as automated dispensing systems, telepharmacy, and electronic health records are enhancing operational efficiency and patient care. The integration of artificial intelligence in drug management and patient monitoring systems is expected to improve accuracy and reduce errors. As of 2025, the pharmacy market is anticipated to witness a growth rate of approximately 10% annually, driven by these technological innovations. Moreover, the adoption of mobile health applications is empowering patients to manage their medications more effectively, thus increasing engagement and adherence to treatment regimens. This technological evolution is likely to redefine the competitive landscape of the pharmacy market.

Market Segment Insights

Pharmacy Market Product Type Insights

The South Korea Pharmacy Market displays a diverse array of product types that underpin its substantial contribution to the national healthcare landscape. Among these, Prescription Drugs constitute a significant element, catering to chronic and acute health needs, making them a cornerstone of therapeutic management in the region. Despite the evolving landscape of healthcare, prescription medications retain a major role due to the rise in chronic diseases and the aging population in South Korea, creating a continuous demand for effective treatment options.

Moreover, Over-The-Counter Drugs play an essential part in the market, providing consumers with accessible solutions for minor health issues, which aligns with the growing trend toward self-medication among the South Korean population. This segment is increasingly favored for its convenience, as it allows individuals to manage their health proactively without needing a prescription. Furthermore, the introduction and expansion of innovative Vaccines dominate the public health initiatives aimed at preventing infectious diseases, especially in light of recent global health crises.

The South Korean government supports vaccine development and accessibility to ensure the well-being of its citizens, bolstering this segment's importance. Lastly, Homeopathic Medicine is gaining traction as consumers seek alternative therapies to complement their traditional treatments, reflecting broader global trends toward holistic health management. This product type resonates well within South Korea’s culturally rich context, where traditional practices often blend with modern healthcare approaches. Collectively, these product types contribute to a dynamic South Korea Pharmacy Market, highlighting trends towards personalization in healthcare and a growing consumer inclination towards preventive health measures.

The overall segmentation illustrates not just the varied nature of healthcare solutions available but also the interplay between consumer behavior, government policy, and emerging health trends in South Korea, each contributing substantially to the pharmacy industry’s growth and evolution.

Source: Primary Research, Secondary Research, Market Research Future Database, and Analyst Review

Pharmacy Market Distribution Channel Insights

The Distribution Channel segment of the South Korea Pharmacy Market plays a critical role in ensuring the timely delivery of pharmaceutical products to consumers. Retail Pharmacy is a prominent channel, offering convenience and accessibility for customers seeking over-the-counter medications and prescription drugs. Hospital Pharmacy, on the other hand, is essential for providing medications directly to patients within healthcare institutions, often ensuring better patient care and adherence to treatment plans. The rising trend of Online pharmacies reflects changing consumer behaviors, driven by the growing demand for digital solutions in health services and the convenience it offers to customers.

Meanwhile, Specialty Pharmacy focuses on high-cost, complex medications, serving patients with chronic or rare conditions, making it a significant player in enhancing patient outcomes. The South Korea Pharmacy Market statistics underscore these diverse channels, highlighting the importance of adapting distribution strategies to meet patient needs efficiently while complying with regulatory frameworks. With advancements in technology and a growing elderly population, opportunities for innovation in distribution channels continue to expand, making this segment vital for the overall market dynamics.

Pharmacy Market Therapeutic Area Insights

The South Korea Pharmacy Market is prominently segmented into the Therapeutic Area, which encompasses critical domains such as Cardiovascular, Oncology, Diabetes, Neurology, and Infectious Diseases. This segmentation reflects the country's growing health concerns, with an increasing prevalence of chronic diseases driving demand for effective pharmaceutical solutions. Cardiovascular diseases remain a leading health issue in South Korea, necessitating a robust focus on preventive and therapeutic measures. Oncology is similarly significant, given the rising cancer rates, thereby urging investment in advanced treatments and Research and Development initiatives.

Diabetes management is crucial, especially with an aging population and lifestyle changes; pharmaceuticals addressing this condition witness substantial uptake. Neurology is another vital area, with the growing incidence of neurological disorders inspiring market innovation. Lastly, Infectious Diseases maintain relevance, particularly post-pandemic, as pharmaceutical companies strive to enhance treatment options and vaccines. Overall, the Therapeutic Area in the South Korea Pharmacy Market demonstrates a keen response to both societal health needs and opportunities for growth, driven by demographic shifts and technological advancements in healthcare delivery.

Pharmacy Market Formulation Insights

The Formulation segment of the South Korea Pharmacy Market plays a crucial role in delivering effective medicinal products to consumers. It encompasses a variety of dosage forms, including Tablets, Injectables, Topicals, and Liquids, catering to different therapeutic needs and patient preferences. Tablets remain a popular choice due to their convenience and ease of administration, making them widely used for chronic diseases. Injectables are critical for immediate therapeutic effects and are often preferred in hospital settings for their quick action, especially in emergency care.

Topicals offer targeted treatment for skin conditions and are important for conditions requiring localized therapy, representing a significant part of patient care. Liquids serve as versatile alternatives for those with difficulty swallowing, particularly in pediatric and geriatric populations, thereby ensuring wider accessibility to medication forms. The South Korea Pharmacy Market is experiencing growth driven by increasing healthcare spending, an aging population, and rising chronic disease prevalence. However, challenges like stringent regulatory requirements can impact the speed to market for new formulations.

Opportunities exist in advancements in drug delivery technologies and personalized medicine, which are shaping the future of formulation products in South Korea.

Get more detailed insights about South Korea Pharmacy Market

Key Players and Competitive Insights

The pharmacy market in South Korea is characterized by a dynamic competitive landscape, driven by factors such as increasing healthcare demands, an aging population, and a growing emphasis on digital health solutions. Major players like CVS Health (US), Walgreens Boots Alliance (US), and Roche (CH) are actively shaping the market through strategic initiatives. CVS Health (US) focuses on expanding its digital health services, enhancing customer engagement through telehealth solutions, while Walgreens Boots Alliance (US) emphasizes partnerships with local healthcare providers to improve service delivery. Roche (CH) is investing in innovative diagnostics and personalized medicine, which positions it favorably in a market that increasingly values tailored healthcare solutions. Collectively, these strategies contribute to a competitive environment that prioritizes innovation and customer-centric services.

Key business tactics within the pharmacy market include localizing manufacturing and optimizing supply chains to enhance efficiency and responsiveness. The market structure appears moderately fragmented, with several key players exerting influence while also allowing for smaller, niche companies to thrive. This fragmentation fosters a competitive atmosphere where companies must continuously innovate and adapt to maintain market share, thereby driving overall growth in the sector.

In October 2025, CVS Health (US) announced a strategic partnership with a leading telehealth provider to enhance its digital health offerings. This move is significant as it aligns with the growing consumer preference for remote healthcare services, potentially increasing CVS's market penetration and customer loyalty. By integrating telehealth into its service portfolio, CVS Health (US) is likely to attract a broader customer base, particularly among tech-savvy younger demographics.

In September 2025, Walgreens Boots Alliance (US) launched a new initiative aimed at expanding its pharmacy services in rural areas of South Korea. This initiative is crucial as it addresses the healthcare accessibility challenges faced by underserved populations. By enhancing its footprint in these regions, Walgreens Boots Alliance (US) not only strengthens its market position but also contributes to improving health outcomes, which may enhance its brand reputation and customer trust.

In August 2025, Roche (CH) unveiled a new line of personalized medicine products tailored for chronic disease management. This strategic move underscores Roche's commitment to innovation and positions the company as a leader in the evolving landscape of precision healthcare. By focusing on personalized solutions, Roche (CH) is likely to differentiate itself from competitors, appealing to healthcare providers and patients seeking targeted therapies.

As of November 2025, current competitive trends in the pharmacy market include a pronounced shift towards digitalization, sustainability, and the integration of artificial intelligence (AI) in operations. Strategic alliances are increasingly shaping the landscape, enabling companies to leverage complementary strengths and enhance service offerings. Looking ahead, competitive differentiation is expected to evolve, with a notable shift from price-based competition to a focus on innovation, technology, and supply chain reliability. This transition may redefine market dynamics, compelling companies to invest in advanced technologies and sustainable practices to meet the changing demands of consumers.

Key Companies in the South Korea Pharmacy Market market include

Industry Developments

Recent developments in the South Korea Pharmacy Market include a notable increase in collaboration and innovation among major companies such as Celltrion, Hanmi Pharmaceutical, and Samsung Biologics, particularly in the biopharmaceutical sector. In October 2023, LG Chem announced a significant investment in expanding its Research and Development operations to enhance its portfolio of biologics and therapeutics, reflecting the growing demand for advanced medical solutions. Furthermore, in August 2023, Daewoong Pharmaceutical made headlines with its strategic partnership involving Yungjin Pharmaceutical to co-develop next-generation biopharmaceuticals, highlighting a trend towards collaborative ventures for accelerated market entry. 

Additionally, in June 2023, Genexine and Merck Korea entered a collaborative agreement focused on immunotherapy, underscoring the ongoing shift towards innovative treatment options. The overall market valuation shows promising growth, driven by the increasing prevalence of chronic diseases and the focus on personalized medicine. Over the past two years, significant advancements in the regulatory environment have favored the introduction of new drugs, and companies are adapting to changing market dynamics through mergers and acquisitions. However, no major mergers have been reported recently among the companies of interest.

Future Outlook

South Korea Pharmacy Market Future Outlook

The Pharmacy Market in South Korea is projected to grow at a 4.1% CAGR from 2024 to 2035, driven by technological advancements, an aging population, and increased healthcare spending.

New opportunities lie in:

  • Expansion of telepharmacy services to enhance patient access and convenience.
  • Development of personalized medication management systems for chronic disease patients.
  • Investment in automated dispensing technologies to improve operational efficiency.

By 2035, the pharmacy market is expected to achieve robust growth, driven by innovation and evolving consumer needs.

Market Segmentation

South Korea Pharmacy Market Formulation Outlook

  • Tablets
  • Injectables
  • Topicals
  • Liquids

South Korea Pharmacy Market Product Type Outlook

  • Prescription Drugs
  • Over-The-Counter Drugs
  • Vaccines
  • Homeopathic Medicine

South Korea Pharmacy Market Therapeutic Area Outlook

  • Cardiovascular
  • Oncology
  • Diabetes
  • Neurology
  • Infectious Diseases

South Korea Pharmacy Market Distribution Channel Outlook

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy
  • Specialty Pharmacy

Report Scope

MARKET SIZE 2024 22.5(USD Billion)
MARKET SIZE 2025 23.42(USD Billion)
MARKET SIZE 2035 35.0(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 4.1% (2024 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled CVS Health (US), Walgreens Boots Alliance (US), Roche (CH), McKesson (US), Cigna (US), Cardinal Health (US), AstraZeneca (GB), Sanofi (FR), GSK (GB), Novartis (CH)
Segments Covered Product Type, Distribution Channel, Therapeutic Area, Formulation
Key Market Opportunities Integration of digital health solutions enhances patient engagement and streamlines pharmacy operations.
Key Market Dynamics Rising demand for personalized medicine drives innovation and competition in South Korea's pharmacy market.
Countries Covered South Korea

Leave a Comment

FAQs

What is the projected market size of the South Korea Pharmacy Market by 2035?

The South Korea Pharmacy Market is expected to reach a value of 15.0 USD Billion by 2035.

What was the value of the South Korea Pharmacy Market in 2024?

In 2024, the South Korea Pharmacy Market is valued at 11.5 USD Billion.

What is the expected CAGR for the South Korea Pharmacy Market from 2025 to 2035?

The market is anticipated to grow at a CAGR of 2.445% from 2025 to 2035.

Which segment of the South Korea Pharmacy Market holds the largest share in 2024?

The Prescription Drugs segment holds the largest share, valued at 5.1 USD Billion in 2024.

What is the anticipated value of Over-The-Counter Drugs in 2035?

The Over-The-Counter Drugs segment is expected to reach 4.0 USD Billion in 2035.

Who are the major players in the South Korea Pharmacy Market?

Key players include Celltrion, LG Chem, Hanmi Pharmaceutical, and other leading companies.

What is the value of the Vaccines segment in 2024?

The Vaccines segment is valued at 2.2 USD Billion in 2024.

How much is the Homeopathic Medicine segment expected to grow by 2035?

The Homeopathic Medicine segment is projected to grow to 1.7 USD Billion by 2035.

What are the growth drivers influencing the South Korea Pharmacy Market?

Growth drivers include an aging population, increased demand for healthcare, and advancements in pharmaceuticals.

What is the projected value of the Prescription Drugs segment by 2035?

The Prescription Drugs segment is projected to be valued at 6.5 USD Billion by 2035.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions